Robert F. Storey

93.1k total citations · 13 hit papers
417 papers, 32.6k citations indexed

About

Robert F. Storey is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Robert F. Storey has authored 417 papers receiving a total of 32.6k indexed citations (citations by other indexed papers that have themselves been cited), including 321 papers in Cardiology and Cardiovascular Medicine, 146 papers in Surgery and 96 papers in Internal Medicine. Recurrent topics in Robert F. Storey's work include Antiplatelet Therapy and Cardiovascular Diseases (265 papers), Acute Myocardial Infarction Research (140 papers) and Venous Thromboembolism Diagnosis and Management (96 papers). Robert F. Storey is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (265 papers), Acute Myocardial Infarction Research (140 papers) and Venous Thromboembolism Diagnosis and Management (96 papers). Robert F. Storey collaborates with scholars based in United Kingdom, United States and Sweden. Robert F. Storey's co-authors include Steen Husted, Stefan James, Lars Wallentin, Philippe Gabríel Steg, Richard C. Becker, Håkan Emanuelsson, Christopher P. Cannon, Hugo A. Katus, Jay Horrow and Robert A. Harrington and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Robert F. Storey

406 papers receiving 31.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2015 5.1k citations Marco Roffi, Carlo Patrono et al. European Heart Journal profile →
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

2009 4.6k citations Lars Wallentin, Richard C. Becker et al. profile →
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

2011 2.3k citations Jeroen J. Bax, Robert F. Storey et al. European Heart Journal profile →
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

2009 794 citations Paul A. Gurbel, Kevin P. Bliden et al. Circulation profile →
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation

2012 763 citations Christian W. Hamm, Jeroen J. Bax et al. profile →
Expert position paper on air pollution and cardiovascular disease

2014 607 citations Robert F. Storey et al. European Heart Journal profile →
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

2010 582 citations Lars Wallentin, Stefan James et al. profile →
ESC/EAS Guidelines for the management of dyslipidaemias

2011 576 citations Robert F. Storey et al. Atherosclerosis profile →
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

2010 436 citations Stefan James, Richard C. Becker et al. profile →
Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC)

2016 413 citations Marco Roffi, Carlo Patrono et al. Giornale italiano di cardiologia profile →
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2015 329 citations Marco Roffi, Carlo Patrono et al. profile →
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease

2016 249 citations Marc P. Bonaca, Deepak L. Bhatt et al. profile →
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

2022 163 citations Diana A. Gorog, Robert F. Storey et al. profile →

Peers

Countries citing papers authored by Robert F. Storey

Since Specialization

Citations

This map shows the geographic impact of Robert F. Storey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Storey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Storey more than expected).

Fields of papers citing papers by Robert F. Storey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Storey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Storey. The network helps show where Robert F. Storey may publish in the future.

Co-authorship network of co-authors of Robert F. Storey

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Storey. A scholar is included among the top collaborators of Robert F. Storey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Storey. Robert F. Storey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study 2025 ·International Journal of COPD ·Dinesh Shrikrishna, John Steer, (unknown), Scott Dickinson, (unknown), (unknown), (unknown), Carol Stonham, Robert F. Storey, Clare Taylor, (unknown), Chris P Gale	1
2	Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure 2024 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Stefan James, Robert F. Storey, Jonas Oldgren	3
3	Oral anticoagulation and non-steroidal anti-inflammatory drugs: a recipe for bleeding 2024 ·European Heart Journal ·William A. Parker, Robert F. Storey	2
4	Temporal biomarker concentration patterns during the early course of acute coronary syndrome 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Kai M. Eggers, Gorav Batra, Bertil Lindahl, Tatevik Ghukasyan Lakic, Johan Lindbäck, Andrzej Budaj, Jan H. Cornel, Evangelos Giannitsis, Hugo A. Katus, Robert F. Storey, Richard C. Becker, Agneta Siegbahn, Lars Wallentin	3
5	Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes 2023 ·Vascular Pharmacology ·William A. Parker, Dominick J. Angiolillo, Fabiana Rollini, Francesco Franchi, Marc P. Bonaca, Deepak L. Bhatt, Philippe Gabríel Steg, (unknown), Mark R. Thomas, Heather M. Judge, Marc S. Sabatine, Robert F. Storey	2
6	Complete Revascularization Versus Culprit-Lesion-Only PCI in STEMI Patients With Diabetes and Multivessel Coronary Artery Disease: Results From the COMPLETE Trial 2023 ·Circulation Cardiovascular Interventions ·(unknown), Vijay Kunadian, David Wood, Robert F. Storey, Sunil V. Rao, Roxana Mehran, Natalia Pinilla‐Echeverri, Thenmozhi Mani, Robert Boone, S.A. Kassam, Matthias Bossard, Samer Mansour, Warren Ball, Matthew Sibbald, Nicholas Valettas, Raúl Moreno, Philippe Gabríel Steg, John A. Cairns, Shamir R. Mehta	6
7	The role of platelet P2Y₁₂ receptors in inflammation 2023 ·British Journal of Pharmacology ·William A. Parker, Robert F. Storey	9
8	Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial 2021 ·Journal of the American Heart Association ·Brian A. Bergmark, Deepak L. Bhatt, Philippe Gabríel Steg, Andrzej Budaj, Robert F. Storey, Yared Gurmu, Julia Kuder, KyungAh Im, Giulia Magnani, Ton Oude Ophuis, Christian W. Hamm, Jindřich Špinar, Róbert Gábor Kiss, Frans Van de Werf, Gilles Montalescot, Per Johanson, Eugene Braunwald, Marc S. Sabatine, Marc P. Bonaca	10
9	Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events 2021 ·European Heart Journal ·Judit Cubedo, Teresa Padró, Gemma Vilahur, Filippo Crea, Robert F. Storey, José Luis López Sendón, Juan Carlos Kaski, Alessandro Sionís, Jordi Sans‐Roselló, Estefanıa Fernández‐Peregrina, (unknown), Lina Badimón	9
10	Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction 2020 ·Circulation Cardiovascular Interventions ·Natalia Pinilla‐Echeverri, Shamir R. Mehta, Wang Jia, Shahar Lavi, Érick Schampaert, Warren J. Cantor, Kevin R. Bainey, Robert C. Welsh, S.A. Kassam, Roxana Mehran, Robert F. Storey, Helen Nguyen, Brandi Meeks, David Wood, John A. Cairns, Tej Sheth	71
11	Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction 2020 ·Diabetes and Vascular Disease Research ·Colin Everett, Catherine Reynolds, Catherine Fernandez, Deborah Stocken, Linda Sharples, Thozhukat Sathyapalan, Simon Heller, Robert F. Storey, Ramzi Ajjan	2
12	Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y12 Inhibition 2020 ·International Journal of Molecular Sciences ·Aitana Braza‐Boïls, Temo Barwari, Clemens Gutmann, Mark R. Thomas, Heather M. Judge, Abhishek Joshi, Raimund Pechlaner, Manu Shankar‐Hari, Ramzi Ajjan, Ian Sabroe, Robert F. Storey, Manuel Mayr	17
13	A Proteomics-Based Assessment of Inflammation Signatures in Endotoxemia 2020 ·Molecular & Cellular Proteomics ·Sean A. Burnap, Ursula Mayr, Manu Shankar‐Hari, Friederike Cuello, Mark R. Thomas, Ajay M. Shah, Ian Sabroe, Robert F. Storey, Manuel Mayr	6
14	ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial 2019 ·Atherosclerosis ·Thor Ueland, Axel Åkerblom, Tatevik Ghukasyan Lakic, Annika E. Michelsen, Richard C. Becker, Maria Bertilsson, Andrzej Budaj, Jan H. Cornel, Anders Himmelmänn, Stefan James, Agneta Siegbahn, Robert F. Storey, Frederic Kontny, Pål Aukrust, Lars Wallentin	4
15	Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes 2019 ·European Heart Journal ·Robert F. Storey, Paul A. Gurbel, Jurriën M. ten Berg, (unknown), George Dangas, Jean‐Marie Frenoux, Diana A. Gorog, Abdel Hmissi, Vijay Kunadian, Stefan James, Jean‐François Tanguay, Henry Tran, Dietmar Trenk, Mike Ufer, Pim van der Harst, Arnoud W.J. van ‘t Hof, Dominick J. Angiolillo	51
16	Abstract 16658: Patient Selection for Long-Term Secondary Prevention With Ticagrelor: Insights From PEGASUS-TIMI 54 2018 ·Circulation ·Marc P. Bonaca, Robert F. Storey, Deepak L. Bhatt, Philippe Gabríel Steg, (unknown), (unknown), Per Johanson, (unknown), Marc S. Sabatine	2
17	Linee guida ESC 2015 per il trattamento delle sindromi coronariche acute nei pazienti senza sopraslivellamento persistente del tratto ST alla presentazione. Task Force per il Trattamento delle Sindromi Coronariche Acute nei Pazienti senza Sopraslivellamento Persistente del Tratto ST alla Presentazione della Società Europea di Cardiologia (ESC) breakdown → 2016 ·Giornale italiano di cardiologia ·Marco Roffi, Carlo Patrono, Jean‐Philippe Collet, Christian Mueller, Marco Valgimigli, Felicita Andreotti, Jeroen J. Bax, Michael A. Borger, Carlos Brotons, Derek P. Chew, Bariş Gencer, Gerd Hasenfuß, Keld Kjeldsen, Patrizio Lancellotti, Ulf Landmesser, Julinda Mehilli, Debabrata Mukherjee, Robert F. Storey, Stephan Windecker	413
18	Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes 2016 ·Thrombosis and Haemostasis ·(unknown), Christian A. Di Buduo, Eti Alessandra Femia, Robert F. Storey, Richard C. Becker, Alessandra Balduini, Sven Nylander, Marco Cattaneo	14
19	Abstract 18427: Impact of Medication on Quantification of Plasma MicroRNAs in Patients With Cardiovascular Disease 2013 ·Circulation ·Dorothee Kaudewitz, Regent Lee, Peter Willeit, Anna Zampetaki, Allison Morton, Timothy D. Warner, Robert F. Storey, Keith M. Channon, Manuel Mayr	0
20	Abstract 5901: The Effect of Ticagrelor in Stable Coronary Artery Disease Patients Nonresponsive to Clopidogrel: The RESPOND Study 2009 ·Circulation ·Paul A. Gurbel, Kevin P. Bliden, Mark J. Antonino, Kathleen Butler, Renli Teng, (unknown), (unknown), Robert F. Storey, Tonny Nielsen, John W. Eikelboom, (unknown), Steen Husted, Dean J. Kereiakes, David Henderson, (unknown), Udaya S. Tantry	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact